SCHEMBL18616406

SCHEMBL18616406

Nc1cc(Cc2cc(-c3ccccc3)no2)c2c(n1)NNN2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 2/20 0.49
▸ MPO P05164 1/20 0.45
▸ CYP11B1 P15538 4/20 0.43
▸ CYP11B2 P19099 3/20 0.43
▸ NPC1 O15118 7/20 0.42
▸ RAB9A P51151 7/20 0.42
▸ SMN1; SMN2 Q16637 5/20 0.42
▸ LMNA P02545 3/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ KCNH2 Q12809 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18618875 0.78 MPO (0.55) MPOCYP11B1CYP11B2MEN1KMT2A
SCHEMBL18618819 0.77 MPO (0.51) MPONPC1RAB9ASMN1; SMN2CYP3A4
SCHEMBL18616409 0.76 NOTUM (0.49) NOTUMMPOCYP11B1CYP11B2NPC1
SCHEMBL18616410 0.75 NOTUM (0.46) NOTUMMPOCYP11B1CYP11B2NPC1
SCHEMBL18620305 0.73 MPO (0.55) MPOCYP3A4
SCHEMBL18621233 0.71 MPO (0.54) MPOSMN1; SMN2LMNAMEN1KMT2A
SCHEMBL1791868 0.71 NOTUM (0.52) NOTUMCYP11B1CYP11B2NPC1RAB9A
SCHEMBL1787674 0.70 NOTUM (0.58) NOTUMMPOCYP11B1CYP11B2NPC1
SCHEMBL28670401 0.69 CYP11B1 (0.66) NOTUMCYP11B1CYP11B2NPC1RAB9A
SCHEMBL18620054 0.68 MPO (0.60) MPOCYP11B1CYP11B2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017040449-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE BRISTOL-MYERS SQUIBB COMPANY (US) 2017-03-09 — — WO disclosed
Send feedback